Long-term response after electrochemotherapy in patients with relapsed or refractory cutaneous melanoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Long-term response after electrochemotherapy in patients with relapsed or refractory cutaneous melanoma ; volume:12 ; number:1 ; day:6 ; month:5 ; year:2014 ; pages:1-2 ; date:5.2014
Journal of translational medicine ; 12, Heft 1 (6.5.2014), 1-2, 5.2014
- Creator
-
Mozzillo, Nicola
- Contributor
-
Caracò, Corrado
Marone, Ugo
Simeone, Ester
Mori, Stefano
Benedetto, Lucia
Di Monta, Gianluca
Di Cecilia, Maria Luisa
Di marzo, Massimiliano
Botti, Gerardo
Ascierto, Paolo Antonio
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-12-S1-P1
- URN
-
urn:nbn:de:1111-2016041450807
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mozzillo, Nicola
- Caracò, Corrado
- Marone, Ugo
- Simeone, Ester
- Mori, Stefano
- Benedetto, Lucia
- Di Monta, Gianluca
- Di Cecilia, Maria Luisa
- Di marzo, Massimiliano
- Botti, Gerardo
- Ascierto, Paolo Antonio
- SpringerLink (Online service)
Other Objects (12)
Dormancy of cutaneous melanoma
Successful Usage of External Beam Radiation to Myeloma Cutaneous Lesions in Patient with Refractory, Relapsed Multiple Myeloma
Cutaneous melanoma in older patients
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients
Hidden Sentinel Node in Cutaneous Melanoma
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of relapsed-refractory diffuse large B cell lymphoma
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone
Analysis of calculated liver scores for long-term outcome in 423 cutaneous melanoma patients
Lower limb cutaneous melanoma surgery: location matters
Dormancy of cutaneous melanoma
Successful Usage of External Beam Radiation to Myeloma Cutaneous Lesions in Patient with Refractory, Relapsed Multiple Myeloma
Cutaneous melanoma in older patients
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients
Hidden Sentinel Node in Cutaneous Melanoma
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of relapsed-refractory diffuse large B cell lymphoma
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone
Analysis of calculated liver scores for long-term outcome in 423 cutaneous melanoma patients
Lower limb cutaneous melanoma surgery: location matters
Dormancy of cutaneous melanoma
Successful Usage of External Beam Radiation to Myeloma Cutaneous Lesions in Patient with Refractory, Relapsed Multiple Myeloma
Cutaneous melanoma in older patients
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients
Hidden Sentinel Node in Cutaneous Melanoma
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of relapsed-refractory diffuse large B cell lymphoma
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone
Analysis of calculated liver scores for long-term outcome in 423 cutaneous melanoma patients